New frontiers in the pharmacological prevention of post-ERCP pancreatitis: The cytokines

Journal of the Pancreas

Volumn 4, Issue 1, 2003, Pages 49-57

  Demols, Anne ^a   Devière, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Acute disease; Cytokines; Interleukin 10; NF kappa B; Pancreatitis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 10; RETINOL; TRYPSINOGEN; TUMOR NECROSIS FACTOR ALPHA;

ACINAR CELL; ACUTE PANCREATITIS; CELL DAMAGE; CELL DEATH; CELL NUCLEUS TRANSPLANTATION; CLINICAL TRIAL; COMMON BILE DUCT STONE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; INCIDENCE; KUPFFER CELL; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MULTIPLE ORGAN FAILURE; NONHUMAN; ODDI SPHINCTER; OXIDATIVE STRESS; PATHOGENESIS; PROSPECTIVE STUDY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; VATER PAPILLOTOMY; ACUTE DISEASE; ANIMAL; DISEASE MODEL; METHODOLOGY; PANCREATITIS; PATHOPHYSIOLOGY;

ACUTE DISEASE; ANIMALS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; PANCREATITIS;

EID: 0037271162     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991; 101:1068-75. [AN 91365172]
2. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990; 36:462-6. [AN 91032838]
3. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1-10. [AN 98347799]
4. Gough DB, Boyle B, Joyce WP, Delaney CP, McGeeney KF, Gorey TF, Fitzpatrick JM. Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis. Br J Surg 1990; 77:1256-9. [AN 91070205]
5. Nonaka A, Manabe T, Tamura K, Asano N, Imanishi K, Yamaki K, Tobe T. [Organ specific ESR features in mouse main organs and ESR application to the model of pancreatic disorders]. Nippon Geka Gakkai Zasshi 1990; 91:169-73. [AN 90220461]
6. Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11:301-12. [AN 97237070]
7. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998; 275:G1402-14. [AN 99061624]
8. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ. Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 2001; 280:G1197-208. [AN 21250583]
9. Dunn JA, Li C, Ha T, Kao RL, Browder W. Therapeutic modification of nuclear factor kappa B binding activity and tumor necrosis factor-alpha gene expression during acute biliary pancreatitis. Am Surg 1997; 63:1036-43. [AN 98054960]
10. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology 1999; 116:420-30. [AN 99122967]
11. Han B, Logsdon CD. Cholecystokinin induction of mob-1 chemokine expression in pancreatic acinar cells requires NF-kappaB activation. Am J Physiol 1999; 277:C74-82. [AN 99345657]
12. Demols A, Le Moine O, Desalle F, Quertinmont E, Van Laethem JL, Deviere J. CD4(+ )T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 2000; 118:582-90. [AN 20167112]
13. Zaninovic V, Gukovskaya AS, Gukovsky I, Mouria M, Pandol SJ. Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells. Am J Physiol Gastrointest Liver Physiol 2000; 279:G666-76. [AN 20461694]
14. Gloor B, Todd KE, Lane JS, Lewis MP, Reber HA. Hepatic Kupffer cell blockade reduces mortality of acute hemorrhagic pancreatitis in mice. J Gastrointest Surg 1998; 2:430-5. [AN 99059989]
15. Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, Reber HA. Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 2000; 21:414-20. [AN 20525256]
16. Pezzilli R, Romboli E, Campana D, Corinaldesi R. Mechanisms Involved in the Onset of Post-ERCP Pancreatitis. JOP. J Pancreas (Online) 2002; 3:162-8. [AN 22319326]
17. Kasugai T, Kuno N, Kizu M. Manometric endoscopic retrograde pancreatography: technique, significance and evaluation. Am J Dig Dis 1974; 19:485-502. [AN 74167051]
18. Deviere J, Le Moine O, van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120:498-505. [AN 21100083]
19. Hietaranta AJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML. Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun 2001; 280:388-95. [AN 21092616]
20. Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis. Gastrointest Endosc 2001; 54:435-40. [AN 21460529]
21. Oezcueruemez-Porsch M, Kunz D, Hardt PD, Fadgyas T, Kress O, Schulz HU, et al. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998; 43:1763-9. [AN 98389559]
22. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909-18. [AN 96365275]
23. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54:425-34. [AN 21460528]
24. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1-10. [AN 98347799]
25. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996; 120:284-8. [AN 96350353]
26. van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108:1917-22. [AN 95286011]
27. Shimizu T, Shiratori K, Sawada T, Kobayashi M, Hayashi N, Saotome H, Keith JC. Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 2000; 21:134-40. [AN 20427446]
28. Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996; 120:515-21. [AN 96378843]
29. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, Gaber AO. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 1996; 62:8-13. [AN 96127847]
30. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR Jr. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117:648-55. [AN 95296868]
31. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, et al. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995; 23:901-8. [AN 95254836]
32. Fujimura K, Kubota Y, Ogura M, Yamaguchi T, Binnaka T, Tani K, et al. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist. J Gastroenterol Hepatol 1992; 7:199-202. [AN 92239729]
33. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994; 81:1783-5. [AN 95128746]
34. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765. [AN 21139833]
35. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274:31868-74. [AN 20011377]
36. Clarke CJ, Hales A, Hunt A, Foxwell BM. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol 1998; 28:1719-26. [AN 98264642]
37. Seitz M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995; 25:1129-32. [AN 95255403]
38. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 2000; 21:134-40. [AN 20427446]
39. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46. [AN 96417481]
40. Dumot JA, Conwell DL, Zuccaro G Jr, Vargo JJ, Shay SS, Easley KA, Ponsky JL. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96:2098-102. [AN 21360265]
41. van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 1997; 113:383-9. [AN 97390597]
42. Guice KS, Miller DE, Oldham KT, Townsend CM Jr, Thompson JC. Superoxide dismutase and catalase: a possible role in established pancreatitis. Am J Surg 1986; 151:163-9. [AN 86127952]
43. Wisner J, Green D, Ferrell L, Renner I. Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut 1988; 29:1516-23. [AN 89092106]
44. Koichiro T, Manabe T, Tobe T. [Effect of shortterm-ischemia and reperfusion on the rat pancreas]. Nippon Geka Hokan 1991; 60:335-41. [AN 92313195]
45. Schoenberg MH, Buchler M, Schadlich H, Younes M, Bultmann B, Beger HG. Involvement of oxygen radicals and phospholipase A2 in acute pancreatitis of the rat. Klin Wochenschr 1989; 67:166-70. [AN 89179733]
46. Schoenberg MH, Buchler M, Gaspar M, Stinner A, Younes M, Melzner I, et al. Oxygen free radicals in acute pancreatitis of the rat. Gut 1990; 31:1138-43. [AN 91192645]
47. Rutledge PL, Saluja AK, Powers RE, Steer ML. Role of oxygen-derived free radicals in diet-induced hemorrhagic pancreatitis in mice. Gastroenterology 1987; 93:41-7. [AN 87219735]
48. Schoenberg MH, Buchler M, Younes M, Kirchmayr R, Bruckner UB, Beger HG. Effect of antioxidant treatment in rats with acute hemorrhagic pancreatitis. Dig Dis Sci 1994; 39:1034-40. [AN 94228873]
49. Luthen R, Grendell JH, Haussinger D, Niederau C. Beneficial effects of L-2-oxothiazolidine-4-carboxylate on cerulein pancreatitis in mice. Gastroenterology 1997; 112:1681-91. [AN 97282539]
50. Neuschwander-Tetri BA, Barnidge M, Janney CG. Cerulein-induced pancreatic cysteine depletion: prevention does not diminish acute pancreatitis in the mouse. Gastroenterology 1994; 107:824-30. [AN 94357383]
51. Wisner JR, Renner IG. Allopurinol attenuates caerulein induced acute pancreatitis in the rat. Gut 1988; 29:926-9. [AN 88284505]
52. Niederau C, Niederau M, Borchard F, Ude K, Luthen R, Strohmeyer G, et al. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Pancreas 1992; 7:486-96. [AN 92350796]
53. Lankisch PG, Pohl U, Otto J, Wereszczynska-Siemiatkowska U, Grone HJ. Xanthine oxidase inhibitor in acute experimental pancreatitis in rats and mice. Pancreas 1989; 4:436-40. [AN 89345475]
54. Rau B, Bauer A, Wang A, Gansauge F, Weidenbach H, Nevalainen T, et al. Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers. Ann Surg 2001; 233:195-203. [AN 21091730]
55. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112:960-7. [AN 97193674]
56. Osman MO, Jacobsen NO, Kristensen JU, Deleuran B, Gesser B, Larsen CG, Jensen SL. IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 1998; 124:584-92. [AN 98408120]
57. Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res 1998; 80:110-4. [AN 99009159]
58. van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998; 43:408-13. [AN 99080856]